Log in to save to my catalogue

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial...

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9495ecf2cf0949c9828f5b817839765a

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye

About this item

Full title

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

Journal of ophthalmology, 2020, Vol.2020 (2020), p.1-8

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Subjects

More information

Scope and Contents

Contents

Aim. A retrospective evaluation of the results of treatment of myopic choroidal neovascularization (mCNV) with intravitreal injections of ranibizumab in a pro re nata (PRN) regimen in three groups of patients distributed according to axial length. Methods. The paper presents a retrospective multicenter study carried out with the cooperation of seve...

Alternative Titles

Full title

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9495ecf2cf0949c9828f5b817839765a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9495ecf2cf0949c9828f5b817839765a

Other Identifiers

ISSN

2090-004X

E-ISSN

2090-0058

DOI

10.1155/2020/3076596

How to access this item